PatientsVille.com LogoPatientsVille.com

Suicide, Attempted | Inpatient Post Admission Cognitive Therapy (PACT) for the Prevention of Suicide Attempts

Suicide, Attempted research study

What is the primary objective of this study?

The broad objective of this research is to effectively utilize a unique window of opportunity during the hospitalization period following a recent suicide attempt to deliver a brief and targeted intervention for suicidal individuals.

Who is eligible to participate?

Inclusion Criteria: - Recent Suicide Attempt - Baseline Completed Preferably within 48 Hours of Admission - Over the Age of 18 - Provides Informed Consent Exclusion Criteria: - Self-Inflicted Harm with No Intent or Desire to Die - Medical Incapacity to Participate - Current State of Active Psychosis - Expected Discharge within 72 Hours of Admission

Which medical condition, disease, disorder, syndrome, illness, or injury is researched?

Suicide, Attempted

Study Interventions

Interventions can include giving participants drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available or noninvasive approaches such as surveys, education, and interviews.

Behavioral:Post Admission Cognitive Therapy (PACT)Individual psychotherapy; 60-90 minutes sessions; 6 sessions over preferably 3 days of inpatient stay

Study Arms

Research studies and clinical trials typically have two or more research arms. An arm is a group of people who receive the same treatment in the study.

Post Admission Cognitive Therapy (PACT)Six (6) 60-90 Minutes Sessions of Post Admission Cognitive Therapy Delivered Preferably Over 3 Consecutive Days of Inpatient Stay

Enhanced Usual Care (EUC)Treatment As Usual and Study Assessment Services

Study Status

Active, not recruiting

Start Date: April 2011

Completed Date: December 2018

Phase: N/A

Type: Interventional

Design:

Primary Outcome: Repeat Suicide Attempts

Secondary Outcome: Depression

Study sponsors, principal investigator, and references

Principal Investigator: Marjan G Holloway, Ph.D.

Lead Sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine

Collaborator: National Alliance for Research on Schizophrenia and Depression

More information:https://clinicaltrials.gov/show/NCT01340859

Discuss Suicide